Characterization of the impact of rpoB mutations on the in vitro and in vivo competitive fitness of Clostridium difficile and susceptibility to fidaxomicin

April 2018

Author(s): Kuehne SA, Dempster AW, Collery MM, Joshi N, Jowett J, Kelly ML, et al

Details: J Antimicrob Chemother. 2018;73(4):973-80

NIHR Acknowledged: Yes

Photo Name Bio